Acadia Healthcare (NASDAQ:ACHC) Issues FY 2024 Earnings Guidance

Acadia Healthcare (NASDAQ:ACHC) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided EPS guidance of 3.350-3.450 for the period, compared to the consensus EPS estimate of 3.520. The company issued revenue guidance of $3.2 billion-$3.2 billion, compared to the consensus revenue estimate of $3.2 billion. Acadia Healthcare also updated its FY24 guidance to $3.35-$3.45 EPS.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on ACHC. Cantor Fitzgerald reissued a “neutral” rating and set a $90.00 price target on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Barclays dropped their target price on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research report on Monday, September 30th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $94.00 price target on shares of Acadia Healthcare in a research report on Friday, September 20th. Deutsche Bank Aktiengesellschaft boosted their price objective on Acadia Healthcare from $70.00 to $75.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Finally, KeyCorp assumed coverage on Acadia Healthcare in a report on Friday, October 11th. They set a “sector weight” rating on the stock. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $86.67.

Acadia Healthcare Stock Performance

Shares of Acadia Healthcare stock traded down $0.67 on Friday, reaching $42.02. 2,707,760 shares of the company were exchanged, compared to its average volume of 981,637. The firm has a market cap of $3.90 billion, a price-to-earnings ratio of 13.78, a P/E/G ratio of 1.50 and a beta of 1.29. Acadia Healthcare has a 1-year low of $41.75 and a 1-year high of $87.77. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.18 and a current ratio of 1.18. The company’s 50-day moving average is $65.72 and its two-hundred day moving average is $67.79.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.28% and a net margin of 8.99%. The company had revenue of $815.60 million for the quarter, compared to analysts’ expectations of $819.42 million. During the same period last year, the business posted $0.91 earnings per share. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. As a group, research analysts expect that Acadia Healthcare will post 3.51 earnings per share for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.